Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.Financial_Report.xls
10-K/A - UNITED STATES SECURITIES AND EXCHANGE COMMISSION - Q Therapeutics, Inc.grace25312011_10kz.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R10.htm
EX-31.2 - EXHIBIT 31 - Q Therapeutics, Inc.f10ka_ex31z2.htm
EX-31.1 - EXHIBIT 31 - Q Therapeutics, Inc.f10ka_ex31z1.htm
EX-32.2 - EXHIBIT 32 - Q Therapeutics, Inc.f10ka_ex32z2.htm
EX-32.1 - EXHIBIT 32 - Q Therapeutics, Inc.f10ka_ex32z1.htm
XML - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc.R11.htm
v2.3.0.15
Equity
12 Months Ended
May 31, 2011
Equity 
Stockholders' Equity Note Disclosure [Text Block]

NOTE 3. PREFERRED STOCK

 

As of May 31, 2011 and 2010, the Company was authorized to issue 10,000,000 shares of preferred stock; zero preferred shares were outstanding.

 

The preferred stock of the Company shall be issued by the Board of Directors of the Company in one or more classes or one or more series within any class and such classes or series shall have such voting powers, full or limited, or no voting powers, and such designations, preferences, limitations or restrictions as the Board of Directors of the Company may determine, from time to time.

 

NOTE 4. COMMON STOCK

 

As of May 31, 2011 and 2010, the Company is authorized to issue 100,000,000 shares of common stock; 100,000 shares of common stock were outstanding.

 

Holders of shares of common stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The common stock does not have cumulative voting rights. No holder of shares of stock of any class shall be entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.

 

NOTE 7. CAPITAL STOCK

 

On July 7, 2008 (the “Effective Date”), pursuant to the terms of a Stock Purchase Agreement (“the Agreement”), Broad Street Ventures, LLC, a limited liability company formed in the State of Colorado purchased a total of 96,000 shares of the issued and outstanding common stock of the Company from Getting You There, LLC, then the sole shareholder of the Company. The total of 96,000 shares represents 96% of the shares of outstanding common stock of the Company (the “Acquisition”). As part of the Acquisition and pursuant to the Agreement, the following changes to the Company’s directors and officers occurred:

 

Virginia K. Sourlis resigned as the Company’s President, Chief Executive Officer, Chief Financial Officer and Secretary and Sole Director effective July 18, 2008.

 

As of July 18 2008, Douglas Dyer was appointed as the Company’s President and Sole Director.